Mga Batayang Estadistika
| CIK | 1300734 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Shineco, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| July 31, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): July 25, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| July 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☐ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☒ Definitive Information Statement SHINECO, INC. (Name of Registrant As |
|
| July 9, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): July 2, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| July 3, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C INFORMATION Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: ☒ Preliminary Information Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) ☐ Definitive Information Statement SHINECO, INC. (Name of Registrant As |
|
| June 30, 2025 |
InfiniClone Limited Unaudited Condensed Financial Statements Exhibit 99.2 InfiniClone Limited Unaudited Condensed Financial Statements CONTENTS PAGE(S) Unaudited Condensed Financial Statements: Unaudited Condensed Balance Sheets as of March 31, 2025 and June 30, 2024 F-2 Unaudited Condensed Statements of loss and Comprehensive loss for the Nine months ended March 31, 2025 and 2024 F-4 Unaudited Condensed Statements of Changes in Shareholders’ Equity for the |
|
| June 30, 2025 |
SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On April 22, 2025, Shineco, Inc. (the “Company”), through its wholly-owned subsidiary, Shineco Life Science Group Hong Kong Co., Limited (“Shineco Life Science”), entered into a share purchase agreement (the “SPA”) with Dr. Lim Kah Meng (“Seller”), the sole shareholder of InfiniClone Limited, a com |
|
| June 30, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 30, 2025 (June 23, 2025) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) ( |
|
| June 30, 2025 |
Report of Independent Registered Public Accounting Firm InfiniClone Limited Financial Statements Exhibit 99.1 Report of Independent Registered Public Accounting Firm And InfiniClone Limited Financial Statements CONTENTS PAGE(S) Report of Independent Registered Public Accounting Firm F-2 Financial Statements: Balance Sheets as of June 30, 2024 and 2023 F-3 Statements of Loss and Comprehensive Loss for the years ended June 30, 2024 and 2023 F-5 Statements of Changes in Shareholders’ Equity for |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 18, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 23, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 16, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 11, 2025 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 11, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 2, 2025 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of May 29, 2025, by and among Shineco, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and condit |
|
| June 2, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 29, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| May 15, 2025 |
Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 14, 2025 (May 13, 2025) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Co |
|
| May 15, 2025 |
Exhibit 99.2 FUWANG (HK) INTERNATIONAL COMPANY LIMITED NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Expressed in US Dollars) FuWang (HK) International Company Limited Unaudited Condensed Consolidated Financial Statements CONTENTS PAGE(S) Unaudited Condensed Consolidated Financial Statements: Unaudited Condensed Consolidated Balance Sheets as of December 31, 2024 and June 30, |
|
| May 15, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Exact |
|
| May 15, 2025 |
SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On March 20, 2025, Shineco, Inc. (the “Company”), through its wholly-owned subsidiary, Shineco Life Science Group Hong Kong Co., Limited (“Shineco Life Science”), entered into a stock purchase agreement (the “SPA”) with Yi Yang (“Seller”), a current and only shareholder of FuWang (HK) International |
|
| May 15, 2025 |
Exhibit 99.1 Report of Independent Registered Public Accounting Firm And FuWang (HK) International Company Limited Consolidated Financial Statements CONTENTS PAGE(S) Report of Independent Registered Public Accounting Firm F-2 Consolidated Financial Statements: Consolidated Balance Sheets as of June 30, 2024 and 2023 F-3 Consolidated Statements of Comprehensive Loss for the years ended June 30, 202 |
|
| May 13, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): May 12, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| April 23, 2025 |
Form of Share Purchase Agreement by and between Shineco Life Science and the Seller Exhibit 10.1 DR. LIM KAH MENG as (“Seller”) and SHINECO LIFE SCIENCE GROUP HONG KONG CO., LTD. as (“Purchaser”) SHARE PURCHASE AGREEMENT TABLE OF CONTENTS Contents Page 1. DEFINITIONS AND INTERPRETATION 1 2. AGREEMENT TO SELL THE SALE SHARES 4 3. CONSIDERATION 4 4. COMPLETION 4 5. REPRESENTATION AND WARRANTIES 5 6. NON-SOLICITATION 10 7. POST-COMPLETION OBLIGATIONS 10 8. BREACH AND TERMINATION 11 |
|
| April 23, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): April 22, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| March 20, 2025 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): March 20, 2025 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| March 20, 2025 |
Form of Stock Purchase Agreement by and between Shineco Life Science and the Seller Exhibit 1.1 STOCK PURCHASE AGREEMENT between Yi Yang And Shineco Life Science Group Hong Kong Co., Limited dated as of March 20, 2025 1 Table of Contents 1. Parties to the Agreement 3 II. Definitions and Interpretation 4 III. Sale and Purchase of Target Equity 5 IV. Pre-Closing Obligations 5 V. Closing Conditions 6 VI. Closing 7 VII. Transaction Consideration and Payment Terms 8 VIII. Transitional |
|
| March 17, 2025 |
Shineco Inc. March 17, 2025 Via Edgar Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C., 20549 Attention: Katherine Bagley Juan Grana Re: Shineco Inc. Registration Statement on Form S-1, as amended Initially Filed on February 18, 2025 File No. 333-285025 Ladies and Gentlemen: In accordance with R |
|
| March 13, 2025 |
Shineco, Inc. March 13, 2025 Via EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Industrial Applications and Services 100 F Street, N.E. Washington, DC 20549 Attention: Ms. Juan Grana Ms. Katherine Bagley Re: Shineco, Inc. Registration Statement on Form S-1 Filed February 18, 2025 File No. 333-285025 Dear Ms. Grana and Ms. Bagley: This letter is in response |
|
| March 13, 2025 |
As filed with the U.S. Securities and Exchange Commission on March 13, 2025 As filed with the U.S. Securities and Exchange Commission on March 13, 2025 Registration No. 333-285025 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 0100 52-2175898 (State or other jurisdiction of incorporation |
|
| March 13, 2025 |
Opinion of Beijing Yingke Law Firm Exhibit 99.1 February 18, 2025 To: Shineco, Inc. Room 1707, Block D, Modern City SOHO, No. 88, Jianguo Road, Chaoyang District Beijing, People’s Republic of China 100022 Re: Legal Opinion Regarding Certain PRC Law Matters To whom it may concern, Beijing Yingke Law Firm (“We”), a qualified law firm of the People’s Republic of China (the “PRC”, for the purpose of issuing this opinion, excluding Hong |
|
| February 18, 2025 |
As filed with the U.S. Securities and Exchange Commission on February 18, 2025 As filed with the U.S. Securities and Exchange Commission on February 18, 2025 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 0100 52-2175898 (State or other jurisdiction of incorporation or organization) (Prim |
|
| February 18, 2025 |
Exhibit 107 Calculation of Filing Fee Tables Form S-1 (Form Type) Shineco, Inc. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Or Carry Forward Rule Amount Registered (1) Proposed Maximum Offering Price Per Share (2) Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Eq |
|
| February 18, 2025 |
Shineco Inc. Room 1707, Block D, Modern City SOHO No. 88, Jianguo Road, Chaoyang District Beijing, People’s Republic of China 100022 February 18, 2025 VIA EDGAR – FORM RW Division of Corporation Finance Office of Industrial Applications and Services U.S. Securities and Exchange Commission 100 F Street, NE Washington, D.C., 20549 Attention: Katherine Bagley Juan Grana Re: Shineco Inc. Rule 477 Appl |
|
| February 18, 2025 |
Exhibit 21.1 List of Subsidiaries, Variable Interest Entities and Subsidiaries of Variable Interest Entities Name of the Entity Percentage Held or Controlled by the Company Subsidiary Shineco Life Science Group Co., Ltd. Hong Kong 100.00 % Shineco Life Science Research Co., Ltd. 100.00 % Fuzhou Meida Health Management Co., Ltd 51.00 % Shinkang Technology (Jiangsu) Co., Ltd. 51.00 % Changzhou Biowi |
|
| February 14, 2025 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Ex |
|
| February 14, 2025 |
Amended and Restated Certificate of Incorporation of Shineco, Inc. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF SHINECO, INC. First. The name of the Corporation is SHINECO, INC. Second. Its registered office in the State of Delaware is to be located at: 15 East North Street, in the City of Dover, County of Kent, Delaware 19901, and its registered agent at such address is: XL CORPORATE SERVICES, INC. Third. The nature of the business and the ob |
|
| February 14, 2025 |
Director Offer letter dated December 3, 2024, by and between the Company and Mr. Jun Fu. Exhibit 10.10 |
|
| February 14, 2025 |
Exhibit 17.1 |
|
| January 14, 2025 |
As filed with the Securities and Exchange Commission on January 14, 2025 As filed with the Securities and Exchange Commission on January 14, 2025 Registration Statement No. |
|
| January 14, 2025 |
Exhibit 107 Calculation of Filing Fee Tables S-3 (Form Type) Shineco, Inc. (Exact name of Registrant as specified in its charter) Table 1: Newly Registered Securities Fee Proposed Calculation Maximum Maximum Security or Carry Offering Aggregate Amount of Security Class Forward Amount Price Per Offering Registration Type Title Rule Registered(1) Unit Price Fee Rate Fee Fees to Be Paid Equity Common |
|
| December 30, 2024 |
Form of Securities Purchase Agreement by and among the Company and the Purchasers Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December 24, 2024, by and among Shineco, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and permitted assigns, a “Purchaser” and collectively, the “Purchasers”). WHEREAS, subject to the terms and c |
|
| December 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2024 (December 24, 2024) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporat |
|
| December 9, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): December 2, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| December 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): November 26, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (E |
|
| November 12, 2024 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): November 12, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| November 12, 2024 |
Shineco Announces Reverse Split to Regain NASDAQ Compliance Exhibit 99.1 Shineco Announces Reverse Split to Regain NASDAQ Compliance BEIJING, November 12, 2024 /PRNewswire/ — Shineco Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer of innovative diagnostic medical products and related medical devices, announced today that effective at 12:01 a.m., EDT, on November 12, 2024, the Company will effect a one-for-twenty four (1-for-24) reverse stock sp |
|
| November 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): November 8, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| November 8, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF SHINECO, INC. Shineco, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: ONE: That the name of the Corporation is Shineco, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of |
|
| October 25, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): October 21, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| October 25, 2024 |
Exhibit 10.1 SHINECO, INC. 2025 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2025 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the “Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Int |
|
| October 4, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| September 30, 2024 |
Exhibit 4.10 AMENDMENT #3 TO CONVERTIBLE PROMISSORY NOTE This Amendment #3 to Convertible Promissory Note (this “Amendment”) is entered into as of June 11, 2024, by and between STREETERVILLE CAPITAL, LLC, a Utah limited liability company (“Lender”), and SHINECO, INC., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to t |
|
| September 30, 2024 |
Exhibit 4.11 AMENDMENT #3 TO CONVERTIBLE PROMISSORY NOTE This Amendment #3 to Convertible Promissory Note (this “Amendment”) is entered into as of June 11, 2024, by and between STREETERVILLE CAPITAL, LLC, a Utah limited liability company (“Lender”), and SHINECO, INC., a Delaware corporation (“Borrower”). Capitalized terms used in this Amendment without definition shall have the meanings given to t |
|
| September 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2024 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. |
|
| September 30, 2024 |
List of subsidiaries of the Company Exhibit 21.1 List of Subsidiaries, Variable Interest Entities and Subsidiaries of Variable Interest Entities Name of the Entity Percentage Held or Controlled by the Company Subsidiary Shineco Life Science Group Co., Ltd. Hong Kong 100.00% Beijing Shineco Chongshi Information Consulting Co., Ltd 100.00% Shineco Life Science Research Co., Ltd. 100.00% Fuzhou Meida Health Management Co., Ltd 51.00% S |
|
| September 24, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| September 18, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): September 10, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission Fi |
|
| September 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): September 3, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission Fil |
|
| September 10, 2024 |
Shineco, Inc. 14,985,000 SHARES OF COMMON STOCK Filed Pursuant to Rule 424(b)(5) Registration No. 333-261229 PROSPECTUS SUPPLEMENT (To the Prospectus Dated June 10, 2022) Shineco, Inc. 14,985,000 SHARES OF COMMON STOCK Pursuant to this prospectus supplement and the accompanying prospectus, Shineco, Inc., a Delaware corporation (“Shineco,” the “Company” or “we”), is offering 14,985,000 shares of its common stock (the “Shares”), par value $0.001 |
|
| August 28, 2024 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of , 2024 by and among Shineco, Inc., a Delaware company (the “Company”), and individuals listed in Exhibit A hereto and each affixes its signature on the signature page of this Agreement (each, a “Purchaser”; collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purchasers |
|
| August 28, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): August 22, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File |
|
| July 17, 2024 |
Shineco Announces Pricing of $2 Million Underwritten Public Offering Exhibit 99.1 Shineco Announces Pricing of $2 Million Underwritten Public Offering Beijing, July 12, 2024 (GLOBE NEWSWIRE) – Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the pricing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $ |
|
| July 17, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): July 11, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| July 17, 2024 |
Exhibit 1.1 UNDERWRITING AGREEMENT between SHINECO, INC. and EF HUTTON LLC as Representative of the Several Underwriters SHINECO, INC. UNDERWRITING AGREEMENT New York, New York July 11, 2024 EF Hutton LLC as Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 39th Floor New York, New York 10022 Ladies and Gentlemen: The undersigned, Shineco, Inc., a c |
|
| July 17, 2024 |
Shineco Announces Closing of $2 Million Underwritten Public Offering Exhibit 99.2 Shineco Announces Closing of $2 Million Underwritten Public Offering Beijing, July 15, 2024 (GLOBE NEWSWIRE) – Shineco, Inc. (“Shineco” or the “Company”) (NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced the closing of its underwritten public offering of 1,869,160 shares of its common stock at a public offering price of $ |
|
| July 15, 2024 |
Shineco, Inc. 1,869,160 SHARES OF COMMON STOCK Filed Pursuant to Rule 424(b)(5) Registration No. 333-261229 PROSPECTUS SUPPLEMENT (To the Prospectus Dated June 10, 2022) Shineco, Inc. 1,869,160 SHARES OF COMMON STOCK Pursuant to this prospectus supplement and the accompanying prospectus, Shineco, Inc., a Delaware corporation (“Shineco”), is offering 1,869,160 shares of common stock, par value $0.001 per share. Each share of common stock is bei |
|
| July 12, 2024 |
SISI / Shineco, Inc. / Huang Shanchun Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 SHINECO, INC. (Name of Issuer) COMMON STOCK, PAR VALUE $0.001 PER SHARE (Title of Class of Securities) 824567408 (CUSIP Number) Shanchun Huang Flat 111 Coleherne Court Old Brompton Road, London SW5 0ED Tel: +447999 688888 (Name, Address and Telephone Number of Person Autho |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): July 9, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| July 11, 2024 |
Exhibit 10.1 JOYWISH Water-Soluble Phospholipid Concentrate Health Food Beverage Distribution Agreement Contract No.： Party A：Fuzhou Meida Health Management Co., Ltd. Party B： Time of signing： Place of signing： Contact No.： Party A： Fuzhou Meida Health Management Co., Ltd. (hereinafter referred to as Party A) Party B： (hereinafter referred to as Party B) In order to further develop the market and |
|
| July 11, 2024 |
Exhibit 99.1 Shineco Announces New Distribution Agreements for up to $38 Million in Sales for its New Health Food Beverage The Company believes that its Advanced Proprietary Production Technology Provides it with a Competitive Advantage in the Sector BEIJING, July 10, 2024 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of innovative diagnostic medical produ |
|
| July 11, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): July 8, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| July 11, 2024 |
SUBJECT TO COMPLETION PRELIMINARY PROSPECTUS SUPPLEMENT DATED JULY 11, 2024 Filed Pursuant to Rule 424(b)(5) Registration No. 333-261229 The information in this preliminary prospectus supplement is not complete and may be changed. This preliminary prospectus supplement and the accompanying prospectus are part of an effective registration statement filed with the U.S. Securities and Exchange Commission under the Securities Act of 1933, as amended. This preliminary prospect |
|
| June 26, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 5, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Num |
|
| June 21, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 20, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 21, 2024 |
Form of Stock Purchase Agreement by and among the Company and the Purchasers Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of June 20, 2024 by and among Shineco, Inc., a Delaware company (the “Company”), and individuals listed in Exhibit B hereto and each affixes its signature on the signature page of this Agreement (each, a “Purchaser”; collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purc |
|
| June 14, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): June 11, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File Nu |
|
| June 13, 2024 |
Exhibit 4.1 SHINECO, INC. 2024 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2024 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the “Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Inte |
|
| June 13, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) T1, South Tower, Jiazhaoye Square Chaoyang District, Beijing, People’s Rep |
|
| June 13, 2024 |
Exhibit 107 Calculation of Filing Fee Tables Form S-8 (Form Type) SHINECO, INC. (Exact Name of Registrant as Specified in its Charter) Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered (1) Proposed Maximum Offering Price Per Share Proposed Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Equity Common Stock, par value |
|
| May 15, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Exact |
|
| April 30, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): April 26, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| March 12, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES AND EXCHANGE ACT OF 1934 Date of report (date of earliest event reported): March 11, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or Other Jurisdiction of Incorporation) (Commission File N |
|
| February 16, 2024 |
Exhibit 3.1 CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF SHINECO, INC. Shineco, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), does hereby certify as follows: ONE: That the name of the Corporation is Shineco, Inc. The original Certificate of Incorporation of the Corporation was filed with the Secretary of State of the State of |
|
| February 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 12, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| February 16, 2024 |
Exhibit 99.1 Shineco Announces 1-for-10 Reverse Stock Split to Regain Compliance with Nasdaq Minimum Bid Requirement BEIJING, February 14, 2024 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a provider of technologically advanced healthcare products and services, announced today that the Company’s Board of Directors has approved a reverse stock split of its issued and |
|
| February 8, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Ex |
|
| February 5, 2024 |
Exhibit 10.1 SHINECO, INC. 2024 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2024 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the “Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Int |
|
| February 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) February 1, 2024 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| January 16, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| January 5, 2024 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| January 4, 2024 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 22, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) |
|
| January 4, 2024 |
Form of Securities Purchase Agreement Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December [*], 2023, between SHINECO, INC., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (including its successors and assigns, the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to |
|
| December 28, 2023 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this “Agreement”) is dated as of December [*], 2023, between SHINECO, INC., a Delaware corporation (the “Company”), and the purchasers identified on the signature page hereto (including its successors and assigns, the “Purchaser”). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to |
|
| December 28, 2023 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 22, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 27, 2023 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 22, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 26, 2023 |
Up to $1,440,000 of Shares of Common Stock Shineco, Inc. Filed Pursuant to Rule 424(b)(5) Registration No. 333-261229 Prospectus Supplement (To Prospectus dated June 10, 2022) Up to $1,440,000 of Shares of Common Stock of Shineco, Inc. Shineco, Inc. (the “Company” or “we”) is offering up to $1,440,000 in shares (“Shares”) of our common stock to certain investors under a purchase agreement entered into on December 22, 2023 (the “Purchase Agreement”) at a |
|
| December 21, 2023 |
Exhibit 3.1 SECOND AMENDED AND RESTATED BYLAWS OF SHINECO, INC. SECOND AMENDED AND RESTATED BYLAWS OF SHINECO, INC. (AS AMENDED December 2023) ARTICLE I — MEETINGS OF STOCKHOLDERS 1.1 Place of Meetings. Meetings of stockholders of Shineco, Inc. (the “Company”) shall be held at any place, within or outside the State of Delaware, designated by the Company’s board of directors (the “Board”). The Boar |
|
| December 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 19, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| December 1, 2023 |
SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.2 SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On May 29, 2023, Shineco, Inc. (the “Company”), through its wholly-owned subsidiary, Shineco Life Science Group Hong Kong Co., Limited (“Life Science HK”), entered into a stock purchase agreement (the “Agreement”) with Dream Partner Limited, a BVI corporation (“Dream Partner”), Chongqing Wintus Gro |
|
| December 1, 2023 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 19, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) |
|
| December 1, 2023 |
Exhibit 99.1 DREAM PARTNER LIMITED CONSOLIDATED FINANCIAL STATEMENTS YEARS ENDED JUNE 30, 2023 AND 2022 AND REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM DREAM PARTNER LIMITED TABLE OF CONTENTS Report of Independent Registered Public Accounting Firm 1 Consolidated Financial Statements Consolidated Balance Sheets 2 Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) 3 |
|
| November 17, 2023 |
Exhibit 10.2 |
|
| November 17, 2023 |
Exhibit 10.1 |
|
| November 17, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) November 13, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| November 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (E |
|
| September 29, 2023 |
Exhibit 4.1 SHINECO, INC. 2023 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2023 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the “Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Inte |
|
| September 29, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) T1, South Tower, Jiazhaoye Square Chaoyang District, Beijing, People’s Rep |
|
| September 29, 2023 |
Exhibit 107 CALCULATION OF REGISTRATION FEE Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, par value $0. |
|
| September 28, 2023 |
Exhibit 4.8 SHINECO, INC. 2023 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2023 Equity Incentive Plan (the “Plan”) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the “Company”), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Inte |
|
| September 28, 2023 |
Exhibit 4.7 |
|
| September 28, 2023 |
Exhibit 10.97 Principal Debt and Real Estate Mortgage Contract (Specific to Real Estate Registration) Mortgagor: Beijing Shineco Chongshi Information Consulting Co., Ltd. (hereinafter referred to as Party A) Address: 519, 5th Floor, Building 2, Yard 9, Huatuo Road, Daxing District, Beijing Mortgagee: Guo Weiqing (hereinafter referred to as Party B) ID number: [ ] Address: No.2, 7th Street, Huaxinl |
|
| September 28, 2023 |
Exhibit 4.5 |
|
| September 28, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2023 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. |
|
| September 28, 2023 |
Exhibit 4.6 |
|
| September 28, 2023 |
Exhibit 4.4 |
|
| September 28, 2023 |
Exhibit 10.98 Loan Agreement Party A (lender): Weiqing Guo ID number: [ ] Party B (Borrower): Yuying Zhang ID number No.: [ ] According to the provisions of relevant laws and regulations such as the Civil Code of the People’s Republic of China, Party A and Party B, on the principles of voluntariness, equality, fairness, and good faith, have reached a consensus through consultation on the matter of |
|
| September 28, 2023 |
Exhibit 10.99 Supplementary Agreement Party A (lender): Weiqing Guo ID number: [ ] Party B (Borrower): Yuying Zhang ID number No.: [ ] On May 24, 2022, Party A and Party B signed the “Loan Agreement”, agreeing that Party A shall lend Party B 15,000,000 RMB, and Party B shall repay the above-mentioned loan in one lump sum on May 23, 2023, but it has not been repaid upon maturity (see the “Loan Agre |
|
| September 21, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 19, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 21, 2023 |
Exhibit 10.1 STOCK PURCHASE AGREEMENT between Wang Xiaohui and Yan Chi Keung (“Sellers”) Dream Partner Limited (“Company”) Shineco, Inc. (“Parent”) Chongqing Wintus Group (“Wintus”) and Shineco Life Science Group Hong Kong Co., Limited (Buyer) dated as of May 29, 2023 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”), dated as of the date first written above, is entered int |
|
| August 29, 2023 |
TYHT / Shineco Inc / Streeterville Capital LLC - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Shineco, Inc. (Name of Issuer) Common stock, $0.001 par value (Title of Class of Securities) 824567309 (CUSIP Number) August 29, 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule |
|
| August 11, 2023 |
August 11, 2023 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D. |
|
| July 24, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 20, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 30, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 28, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| June 23, 2023 |
Securities Purchase Agreement, dated June 21, 2023 Exhibit 10.2 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of June 21, 2023 by and among Shineco, Inc., a Delaware company (the “Company”), and individuals listed in Exhibit B hereto and each affixes its signature on the signature page of this Agreement (each, a “Purchaser”; collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purc |
|
| June 23, 2023 |
Securities Purchase Agreement, dated June 19, 2023 Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the “Agreement”) is dated as of June 19, 2023 by and among Shineco, Inc., a Delaware company (the “Company”), and individuals listed in Exhibit B hereto and each affixes its signature on the signature page of this Agreement (each, a “Purchaser”; collectively, the “Purchasers”). RECITALS WHEREAS, the Company and the Purc |
|
| June 23, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 19, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 16, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☒ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| June 2, 2023 |
Exhibit 10.1 STOCK PURCHASE AGREEMENT between Wang Xiaohui and Yan Chi Keung (“Sellers”) Dream Partner Limited (“Company”) Shineco, Inc. (“Parent”) Chongqing Wintus Group (“Wintus”) and Shineco Life Science Group Hong Kong Co., Limited (Buyer) dated as of May 29, 2023 STOCK PURCHASE AGREEMENT This Stock Purchase Agreement (this “Agreement”), dated as of the date first written above, is entered int |
|
| June 2, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) May 29, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 30, 2023 |
May 30, 2023 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D. |
|
| May 18, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ☒ Definitive Proxy State |
|
| May 12, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Exact |
|
| March 23, 2023 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 20, 2023 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number |
|
| February 27, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 30, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) |
|
| February 27, 2023 |
SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Exhibit 99.3 SHINECO, INC. UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION Introduction On October 21, 2022, Shineco, Inc. (the “Company”), through its wholly-owned subsidiary, Shineco Life Science Research Co., Ltd. (“Shineco Life Science”), entered into a stock purchase agreement (the “Agreement”) with Beijing Kanghuayuan Medicine Information Consulting Co., Ltd., a company establis |
|
| February 27, 2023 |
Exhibit 99.1 BIOWIN PHARMACEUTICAL CO., LTD. CONSOLIDATED FINANCIAL STATEMENTS YEARS ENDED JUNE 30, 2022 AND 2021 AND REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM BIOWIN PHARMACEUTICAL CO., LTD. TABLE OF CONTENTS Report of Independent Registered Public Accounting Firm 1 Consolidated Financial Statements Consolidated Balance Sheets 2 Consolidated Statements of Income (Loss) and Comprehen |
|
| February 27, 2023 |
Exhibit 99.2 BIOWIN PHARMACEUTICAL CO., LTD. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS SIX MONTHS ENDED DECEMBER 31, 2022 AND 2021 BIOWIN PHARMACEUTICAL CO., LTD. TABLE OF CONTENTS Unaudited Condensed Consolidated Financial Statements Unaudited Condensed Consolidated Balance Sheets 1 Unaudited Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) 2 Unaudite |
|
| February 14, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Ex |
|
| January 18, 2023 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): January 18, 2023 (January 17, 2023) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) ( |
|
| January 18, 2023 |
Exhibit 99.1 Shineco Entered Into Framework Agreement Relating to Acquisition of Antiviral Fabric Producer Chongqing Wintus Group BEIJING, January 17, 2023 (GLOBE NEWSWIRE) – Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural products and other biotech products, announced today that on January 13, 2023, the Company |
|
| January 4, 2023 |
Exhibit 10.2 Supplementary Agreement to the Stock Purchase Agreement This Supplementary Agreement to the Stock Purchase Agreement (hereinafter referred to as ?the Agreement?) is signed by the following parties in Chaoyang District, Beijing, China on December 30, 2022: Seller?Beijing Kanghuayuan Medicine Information Consulting Co., Ltd.??Kanghuayuan?? Buyer?Shineco Life Science Research Co., Ltd.?? |
|
| January 4, 2023 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): (December 31, 2022) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File |
|
| January 4, 2023 |
Exhibit 10.1 Stock Purchase Agreement between Beijing Kanghuayuan Medicine Information Consulting Co., Ltd. and Shineco Life Science Research Co., Ltd. Oct. 21, 2022 CONTENTS 2 I. The Parties 4 II. Definitions and Interpretation 5 III. Sale and purchase of target equity 6 IV. Obligations prior to closing 7 V. Closing conditions 7 VI. Closing 9 VII. Transaction consideration and payment terms 9 VII |
|
| December 22, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 22, 2022 (December 21, 2022) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) |
|
| November 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (E |
|
| October 25, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): October 25, 2022 (October 21, 2022) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) ( |
|
| October 25, 2022 |
Exhibit 99.1 Shineco, Inc. to Acquire Controlling Equity Interest in Changzhou Biowin Pharmaceutical Co., Ltd to Step into Point-of-Care Testing Industry BEIJING, October 25, 2022, (GLOBE NEWSWIRE) — Shineco, Inc.(“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on October 21, 2022, th |
|
| September 30, 2022 |
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) September 29, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 28, 2022 |
List of subsidiaries of the Company. Exhibit 21.1 List of Subsidiaries, Variable Interest Entities and Subsidiaries of Variable Interest Entities Name of the Entity Percentage Held or Controlled by the Company VIE Qingdao Zhihesheng Agricultural Produce Services, Ltd. VIE Yantai Zhisheng International Freight Forwarding Co., Ltd. VIE Yushe County Guangyuan Forest Development Co., Ltd. VIE Shineco Zhisheng (Beijing) Bio-Technology Co. |
|
| September 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2022 or ☐ Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. |
|
| August 26, 2022 |
TYHT / Shineco Inc / Huang Shanchun Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D (Rule 13d-101) Information to be Included in Statements Filed Pursuant to ? 240. |
|
| August 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 17, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 19, 2022 |
Exhibit 10.1 SHINECO, INC. Room3310, North Tower, Zhengda Center, No. 20, Jinhe East Road, Chaoyang District, Beijing People’s Republic of China 100020 August 17, 2022 Re: Director Offer Letter for a Director Dear Mr. Aamir Ali Quraishi, Shineco, Inc., a Delaware corporation (the “ Company”) , is pleased to offer you a position as member of its board of directors (the “ Board”) . We believe your b |
|
| August 17, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 11, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 17, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of August 11, 2022, between SHINECO, INC., a Delaware corporation (the ?Company?), and the purchasers identified on the signature page hereto (including its successors and assigns, the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an |
|
| August 16, 2022 |
Up to $1,758,340 of Shares of Common Stock Shineco, Inc. 424B5 1 form424b5.htm Filed Pursuant to Rule 424(b)(5) Registration No. 333-250160 Prospectus Supplement (To Prospectus dated June 23, 2021) Up to $1,758,340 of Shares of Common Stock of Shineco, Inc. Shineco, Inc. (the “Company” or “we”) is offering up to $1,758,340 in shares (“Shares”) of our common stock to one investor under a purchase agreement entered into on August 11, 2022 (the “Purchase A |
|
| August 15, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) August 10, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numbe |
|
| August 1, 2022 |
Unregistered Sales of Equity Securities, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 26, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 29, 2022 |
EX-FILING FEES 5 ex107.htm Exhibit 107 CALCULATION OF REGISTRATION FEE Table 1: Newly Registered Securities Security Type Security Class Title Fee Calculation Rule Amount Registered(1) Proposed Maximum Offering Price Per Share Maximum Aggregate Offering Price Fee Rate Amount of Registration Fee Fees to Be Paid Equity Common Stock, par value $0.001 per share 457(c) and (h) 1,500,000 (2) $ 1.01 (3) |
|
| July 29, 2022 |
Exhibit 4.1 SHINECO, INC. 2022 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2022 Equity Incentive Plan (the ?Plan?) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the ?Company?), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Inte |
|
| July 29, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Room3310, North Tower, Zhengda Center No. 20, Jinhe East Road, Chaoyang Di |
|
| July 27, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 21, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 25, 2022 |
Exhibit 10.1 SHINECO, INC. 2022 SHARE INCENTIVE PLAN 1. Purpose of the Plan. This 2022 Equity Incentive Plan (the ?Plan?) is intended as an incentive, to retain in the employment of and as directors, officers, consultants, advisors and employees to Shineco, Inc., a Delaware corporation (the ?Company?), and any Subsidiary of the Company, within the meaning of Section 424(f) of the United States Int |
|
| July 25, 2022 |
Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) July 21, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| July 5, 2022 |
DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by |
|
| June 24, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the Appropriate Box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ? Defin |
|
| June 17, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 17, 2022 (June 13, 2022) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commiss |
|
| June 17, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This SECURITIES PURCHASE AGREEMENT (the ?Agreement?) is dated as of June 13, 2022 by and among Shineco, Inc., a Delaware company (the ?Company?), and individuals listed in Exhibit B hereto and each affixes its signature on the signature page of this Agreement (each, a ?Purchaser?; collectively, the ?Purchasers?). RECITALS WHEREAS, the Company and the Purc |
|
| June 13, 2022 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) June 8, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| June 8, 2022 |
CORRESP 1 filename1.htm SHINECO, INC. Room 3310, North Tower, Zhengda Center No. 20, Jinhe East Road, Chaoyang District, Beijing, People’s Republic of China 100020 June 8, 2022 Securities and Exchange Commission Division of Corporation Finance 100 F Street N.E. Washington, D.C. 20549 Attention: Mr. Chris Edwards and Ms. Celeste Murphy Re: Shineco, Inc. Registration Statement on Form S-3/A Submitte |
|
| June 3, 2022 |
June 3, 2022 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D. |
|
| June 3, 2022 |
As filed with the Securities and Exchange Commission on June 3, 2022 S-3/A 1 forms-3a.htm As filed with the Securities and Exchange Commission on June 3, 2022 Registration No. 333-261229 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3/A (Amendment No. 2) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of inco |
|
| May 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the Appropriate Box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ? Defin |
|
| May 19, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ? Filed by a party other than the Registrant ? Check the Appropriate Box: ? Preliminary Proxy Statement ? Confidential, for Use of the Commission Only (as Permitted by Rule 14a-6(e)(2)) ? Defin |
|
| May 16, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Exact |
|
| May 11, 2022 |
Exhibit 107 Calculation of Filing Fee Tables Form S-3 (Form Type) Shineco, Inc. (Exact Name of Registrant as Specified in its Charter) Security Type Security Class Title Fee Calculation Rule Amount Registered (1)(2) Proposed Maximum Aggregate Offering Price Per Share (1)(2) Maximum Aggregate Offering Price (1)(2)(3) Fee Rate Amount of Registration Fee (3) Equity Common stock, $0.001 par value per |
|
| May 11, 2022 |
As filed with the Securities and Exchange Commission on May 11, 2022 S-3/A 1 forms-3a.htm As filed with the Securities and Exchange Commission on May 11, 2022 Registration No. 333-261229 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3/A (Amendment No. 1) REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of inco |
|
| May 11, 2022 |
May 11, 2022 Securities and Exchange Commission Division of Corporate Finance 100 F Street, NE Washington, D. |
|
| April 28, 2022 |
DEF 14A 1 formdef14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a party other than the Registrant ☐ Check the Appropriate Box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as Permitted by |
|
| April 14, 2022 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) April 11, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number |
|
| April 14, 2022 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of April 11, 2022, between SHINECO, INC., a Delaware corporation (the ?Company?), and the purchaser identified on the signature page hereto (including its successors and assigns, the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an ef |
|
| April 14, 2022 |
Exhibit 99.1 Shineco, Inc. Announces Entering into a Securities Purchase Agreement with Gross Proceeds of US$2.2 Million BEIJING, April 14, 2022 (GLOBE NEWSWIRE) - Shineco, Inc. (?Shineco? or the ?Company?; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a securities purchase agreement (the ? |
|
| April 12, 2022 |
Up to $2,200,000 of Shares of Common Stock Shineco, Inc. Filed Pursuant to Rule 424(b)(5) Registration No. 333-250160 Prospectus Supplement (To Prospectus dated June 23, 2021) Up to $2,200,000 of Shares of Common Stock of Shineco, Inc. Shineco, Inc. (the ?Company? or ?we?) is offering up to $2,200,000 in shares (?Shares?) of our common stock to one investor under a purchase agreement entered into on April 11, 2022 (the ?Purchase Agreement?) at a per sha |
|
| March 28, 2022 |
Shineco, Inc. Announces Board and Officer Changes EX-99 2 ex99-1.htm Exhibit 99.1 Shineco, Inc. Announces Board and Officer Changes BEIJING, March 28, 2022 (GLOBE NEWSWIRE) — Shineco, Inc. (“Shineco” or the “Company”; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, today announced the board of directors (the “Board”) and officer changes effective on March 25, 2022. Effective |
|
| March 28, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) March 25, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number |
|
| February 14, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (Ex |
|
| February 10, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K/A (Amendment No. |
|
| February 3, 2022 |
Exhibit 99.1 Shineco, Inc. Enters Into Cooperation Agreement to Jointly Manufacture PET and Explore High-end Medical Imaging Devices Field BEIJING, February 3, 2022 (GLOBE NEWSWIRE) ? Shineco, Inc. (?Shineco? or the ?Company?; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that on January 30, 2022, the Company enter |
|
| February 3, 2022 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 30, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| January 19, 2022 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) January 18, 2022 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| January 19, 2022 |
Exhibit 10.1 Re: [name of a Selling Shareholder] and Shineco Life Sciences Incorporation (Shineco, Inc.) Equity Transfer Agreement 01/18/2022 (Page 2) Content 1. The parties in the agreement 3 2. Definition and explanation 3 3. Sale and purchase of Target Equity 5 4. Obligations before closing 5 5. Closing conditions 5 6. Closing 6 7. Transaction consideration and payment conditions 6 8. Transitio |
|
| December 6, 2021 |
Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported) December 6, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| December 6, 2021 |
Exhibit 99.1 Shineco, Inc. Announces Entering Into a Securities Purchase Agreement with GHS Investments, LLC with Gross Proceeds of $2.0 Million USD BEIJING, December 6, 2021 (GLOBE NEWSWIRE) ? Shineco, Inc. (?Shineco? or the ?Company?; NASDAQ: SISI), a producer and distributor of Chinese herbal medicines, organic agricultural and other biotech products, announced that it has entered into a securi |
|
| December 6, 2021 |
Exhibit 10.1 SECURITIES PURCHASE AGREEMENT This Securities Purchase Agreement (this ?Agreement?) is dated as of December 6, 2021, between SHINECO, INC., a Delaware corporation (the ?Company?), and the purchaser identified on the signature page hereto (including its successors and assigns, the ?Purchaser?). WHEREAS, subject to the terms and conditions set forth in this Agreement and pursuant to an |
|
| December 6, 2021 |
291,775 Shares of Common Stock Shineco, Inc. Filed Pursuant to Rule 424(b)(5) Registration No. 333-250160 Prospectus Supplement (To Prospectus dated June 23, 2021) 291,775 Shares of Common Stock of Shineco, Inc. This prospectus supplement relates to the issuance and sale of 291,775 shares (the ?Shares?) of common stock of Shineco, Inc. (the ?Company? or ?we?) to GHS Investments, LLC (?GHS?), under a purchase agreement entered into on Decembe |
|
| November 19, 2021 |
Exhibit 4.1 INDENTURE Dated as of , 20 Between Shineco, Inc. as Issuer And [], as Trustee Debt Securities TABLE OF CONTENTS Page ARTICLE I DEFINITIONS AND INCORPORATION BY REFERENCE 1 SECTION 1.01. Definitions 1 SECTION 1.02. Other Definitions 3 SECTION 1.03 Incorporation by Reference of Trust Indenture Act 3 SECTION 1.04 Rules of Construction 3 ARTICLE II THE SECURITIES 4 SECTION 2.01 Unlimited i |
|
| November 19, 2021 |
Power of Attorney (included on signature page)** S-3 1 forms-3.htm As filed with the Securities and Exchange Commission on November 19, 2021 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 52-2175898 (State or other jurisdiction of incorporation or organizatio |
|
| November 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (E |
|
| November 4, 2021 |
Letter from Centurion ZD CPA & Co. dated November 4, 2021 EX-16.1 2 ex16-1.htm Exhibit 16.1 中正達會計師事務所 Centurion ZD CPA & Co. Certified Public Accountants (Practising) Unit 1304, 13/F, Two Harbourfront, 22 Tak Fung Street, Hunghom, Hong Kong. 香港 紅磡 德豐街22 號 海濱廣場二期 13樓1304室 Tel 電話: (852) 2126 2388 Fax 傳真: (852) 2122 9078 Email 電郵: [email protected] November 4, 2021 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We ha |
|
| November 4, 2021 |
Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):October 29, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| October 15, 2021 |
Shineco, Inc. Announces Nasdaq Ticker Symbol Change from “TYHT” to “SISI” Exhibit 99.1 Shineco, Inc. Announces Nasdaq Ticker Symbol Change from ?TYHT? to ?SISI? BEIJING, October 15, 2021 (GLOBE NEWSWIRE) ? Shineco, Inc. (?Shineco? or the ?Company?; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products and other biotech products, announced that its ticker symbol on the Nasdaq Stock Market (NASDAQ) will change to ?SI |
|
| October 15, 2021 |
Regulation FD Disclosure, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported):October 15, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| September 30, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ? annual report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the fiscal year ended June 30, 2021 or ? Transition report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. |
|
| September 30, 2021 |
List of subsidiaries of the Company. Exhibit 21.1 List of Subsidiaries The list of the Company?s subsidiaries and affiliated entities as of June 30, 2021 is as follows: Subsidiaries Place of Incorporation Ownership Percentage Beijing Tenet Jove Technological Development Co., Ltd. Beijing, China 100% Tianjin Tenet Huatai Technological Development Co., Ltd. Tianjin, China 90% Xinjiang Tianyi Taihe Agricultural Science & Technology Co., |
|
| September 29, 2021 |
NT 10-K 1 formnt-10k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): ☒ Form 10-K ☐ Form 20-F ☐ Form 11-K ☐ Form 10-Q ☐ Form 10-D ☐ Form N-CEN ☐ Form N-CSR For Period Ended: June 30, 2021 ☐ Transition Report on Form 10-K ☐ Transition Report on Form 20-F ☐ Transition Report on Form 11-K ☐ Transition Report on Form 10-Q |
|
| September 9, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 2, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Nu |
|
| September 9, 2021 |
Exhibit 10.1 SHINECO, INC. Room 1001, Building T5, DaZu Square, Daxing District, Beijing 100176 People?s Republic of China September 2, 2021 Re: Director Offer Letter for a Director Dear Mr. Hu Li, Shineco, Inc., a Delaware corporation (the ?Company?), is pleased to offer you a position as member of its board of directors (the ?Board?). We believe your background and experience will be a significa |
|
| August 24, 2021 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-250160 Prospectus Supplement (To Prospectus dated June 21, 2021) Shineco, Inc. $10,000,000 of Shares of Common Stock Underlying 6% Convertible Promissory Note due 2022 This prospectus supplement covers the issuance of US$10,000,000 worth of our common stock, par value $0.001, issuable to an institutional accredited investor (“Noteholder”) upon |
|
| August 23, 2021 |
Exhibit 10.1 Securities Purchase Agreement This Securities Purchase Agreement (this ?Agreement?), dated as of August 19, 2021, is entered into by and between Shineco, Inc., a Delaware corporation (?Company?), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (?Investor?). A. Company and Investor are executing and delivering this Agreement in reliance u |
|
| August 23, 2021 |
EXHIBIT 4.1 CONVERTIBLE PROMISSORY NOTE Effective Date: August 19, 2021 U.S. $10,520,000.00 FOR VALUE RECEIVED, Shineco, Inc., a Delaware corporation (?Borrower?), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (?Lender?), $10,520,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is twelve (12) mo |
|
| August 23, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 23, 2021 (August 19, 2021) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Co |
|
| August 16, 2021 |
Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| August 2, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [ ] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [X] Definitive Information Statement SHINECO, INC. (Name of Regi |
|
| July 29, 2021 |
Filed Pursuant to Rule 424(b)(5) Registration No. 333-250160 Prospectus Supplement (To Prospectus dated June 21, 2021) Shineco, Inc. $7,500,000 of Shares of Common Stock Underlying 6% Convertible Promissory Notes due 2022 This prospectus supplement covers the issuance of US$7,500,000 worth of our common stock, par value $0.001, issuable to an institutional accredited investor (?Noteholder?) upon t |
|
| July 22, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14C (Rule 14c-101) Information Statement Pursuant to Section 14(c) of the Securities Exchange Act of 1934 Check the appropriate box: [X] Preliminary Information Statement [ ] Confidential, for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) [ ] Definitive Information Statement SHINECO, INC. (Name of Regi |
|
| July 21, 2021 |
Exhibit 4.3 CONVERTIBLE PROMISSORY NOTE #2 Effective Date: July 16, 2021 U.S. $4,200,000.00 FOR VALUE RECEIVED, Shineco, Inc., a Delaware corporation (?Borrower?), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (?Lender?), $4,200,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is twelve (12) mon |
|
| July 21, 2021 |
Exhibit 4.2 CONVERTIBLE PROMISSORY NOTE #1 Effective Date: July 16, 2021 U.S. $3,170,000.00 FOR VALUE RECEIVED, Shineco, Inc., a Delaware corporation (?Borrower?), promises to pay to Streeterville Capital, LLC, a Utah limited liability company, or its successors or assigns (?Lender?), $3,170,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is twelve (12) mon |
|
| July 21, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2021 (June 16, 2021) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commis |
|
| July 21, 2021 |
Exhibit 10.2 Securities Purchase Agreement This Securities Purchase Agreement (this ?Agreement?), dated as of July 16, 2021, is entered into by and between Shineco, Inc., a Delaware corporation (?Company?), and Streeterville Capital, LLC, a Utah limited liability company, its successors and/or assigns (?Investor?). A. Company and Investor are executing and delivering this Agreement in reliance upo |
|
| July 21, 2021 |
Exhibit 10.1 Securities Purchase Agreement THIS SECURITIES PURCHASE AGREEMENT (this ?Agreement?), dated as of June 16, 2021, is entered into by and between SHINECO, INC., a Delaware corporation (?Company?), and STREETERVILLE CAPITAL, LLC, a Utah limited liability company, its successors and/or assigns (?Investor?). A. Company and Investor are executing and delivering this Agreement in reliance upo |
|
| July 21, 2021 |
Exhibit 4.1 CONVE RTIBLE P ROMISSORY NOTE Effective Date: June 16, 2021 U.S. $3,170,000.00 FOR VALUE RECEIVED, SHINECO, INC., a Delaware corporation (?Borrower?), promises to pay to STREETERVILLE CAPITAL, LLC, a Utah limited liability company, or its successors or assigns (?Lender?), $3,170,000.00 and any interest, fees, charges, and late fees accrued hereunder on the date that is twelve (12) mont |
|
| July 16, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 16, 2021 (July 15, 2021) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commis |
|
| July 16, 2021 |
EX-10.1 2 ex10-1.htm Exhibit 10.1 EMPLOYMENT AGREEMENT This Employment Agreement (this “Agreement”) is made as of July 15, 2021 (the “Effective Date”) between Shineco, Inc., with an address of Room 1001, Building T5, DaZu Square, Daxing District, Beijing, People’s Republic of China 100176 (“Company”), and Jennifer Zhan, with an address at [**] (“Employee”) (Company and Employee are each a “Party” |
|
| July 15, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 14, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number |
|
| July 15, 2021 |
Exhibit 10.1 SHINECO, INC. Room 1001, Building T5, DaZu Square, Daxing District, Beijing 100176 People?s Republic of China July 14, 2021 Re: Director Offer Letter for a Director Dear Ms. Jennifer Zhan, Shineco, Inc., a Delaware corporation (the ?Company?), is pleased to offer you a position as member of its board of directors (the ?Board?). We believe your background and experience will be a signi |
|
| July 15, 2021 |
Exhibit 10.2 SHINECO, INC. Room 1001, Building T5, DaZu Square, Daxing District, Beijing 100176 People?s Republic of China July 14, 2021 Re: Director Offer Letter for a Director Dear Mr. Mike Zhao, Shineco, Inc., a Delaware corporation (the ?Company?), is pleased to offer you a position as member of its board of directors (the ?Board?). We believe your background and experience will be a significa |
|
| July 12, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 11, 2021 (July 7, 2021) SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commiss |
|
| June 21, 2021 |
CORRESP 1 filename1.htm Shineco, Inc. Room 1001, Building T5, DaZu Square, Daxing District, Beijing People’s Republic of China 100076 (+86) 10-58693193 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, DC 20549 June 21, 2021 Re: Shineco, Inc. Registration Statement on Form S-3, as amended Initially Filed on November 18, 2020 F |
|
| June 21, 2021 |
As filed with the securities and exchange commission on June 21, 2021 As filed with the securities and exchange commission on June 21, 2021 Registration No. |
|
| June 21, 2021 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 15, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number |
|
| June 11, 2021 |
EX-10.8 98 ex10-8.htm Exhibit 10.8 |
|
| June 11, 2021 |
Exhibit 10.9 Termination Agreement This Termination Agreement (this ?Agreement?) is made and entered into by and among the following parties on June 8, 2021 in Beijing. (1) Beijing Tenet Jove Technological Development Co., Ltd., a company established and validly existing under the laws of People?s Republic of China, the address is No.1008, Floor 9, Building 1, No. 2 Yard, Boxing 9th Road, Economic |
|
| June 11, 2021 |
Exhibit 10.1 Among Shineco Inc. Beijing Tenet Jove Technological Development Co., Ltd. Ankang Changshou Pharmaceutical Group Jiping Chen Xiaoyan Chen And Yushe County Guangyuan Forest Development Co., Ltd. Baolin Li Yufeng Zhang Restructuring Framework Agreement Date: June 8, 2021 Restructuring Framework Agreement This Restructuring Framework Agreement (this ?Agreement?) is made and entered into b |
|
| June 11, 2021 |
EX-10.2 3 ex10-2.htm Exhibit 10.2 |
|
| June 11, 2021 |
Exhibit 10.6 |
|
| June 11, 2021 |
Exhibit 10.4 |
|
| June 11, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities and Exchange Act of 1934 Date of Report (Date of earliest event reported): June 8, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Num |
|
| June 11, 2021 |
Exhibit 10.7 |
|
| June 11, 2021 |
Exhibit 10.3 |
|
| June 11, 2021 |
EX-10.5 57 ex10-5.htm Exhibit 10.5 |
|
| June 1, 2021 |
Shineco, Inc. Announces It’s Unaware of Reason for Stock Volatility Exhibit 99.1 Shineco, Inc. Announces It?s Unaware of Reason for Stock Volatility BEIJING, June 1, 2021 (GLOBE NEWSWIRE) ? Shineco, Inc. (?Shineco? or the ?Company?; NASDAQ: TYHT), a producer and distributor of Chinese herbal medicines, organic agricultural and hemp products, today announced in response to unusual market activity, and after speaking with its officers, directors, major shareholders |
|
| June 1, 2021 |
Other Events, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 27, 2021 |
DEFA14A 1 formdefa14a.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant [X] Filed by a party other than the Registrant [ ] Check the Appropriate Box: [ ] Preliminary Proxy Statement [ ] Confidential, for Use of the Commission Only (as Perm |
|
| May 26, 2021 |
Director Offer Letter dated May 24, 2021 by and between Shineco, Inc. and Minye Wang Exhibit 10.1 SHINECO, INC. Room 1001, Building T5, DaZu Square, Daxing District, Beijing 100176 People?s Republic of China May 24, 2021 Ms. Minye Wang [*] Re: Director Offer Letter for a Director Dear Ms. Wang, Shineco, Inc., a Delaware corporation (the ?Company?), is pleased to offer you a position as member of its board of directors (the ?Board?). We believe your background and experience will b |
|
| May 26, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 20, 2021 SHINECO, INC. (Exact name of registrant as specified in its charter) Delaware 001-37776 52-2175898 (State or other jurisdiction of incorporation) (Commission File Number) |
|
| May 26, 2021 |
Director Offer Letter dated May 24, 2021 by and between Shineco, Inc. and Lei Gao Exhibit 10.2 SHINECO, INC. Room 1001, Building T5, DaZu Square, Daxing District, Beijing 100176 People?s Republic of China May 24, 2021 Mr. Lei Gao [*] Re: Director Offer Letter for An Independent Director Dear Mr. Gao, Shineco, Inc., a Delaware corporation (the ?Company?), is pleased to offer you a position as member of its board of directors (the ?Board?). We believe your background and experien |
|
| May 14, 2021 |
Exhibit 10.3 Equity Transfer Agreement Transferor: An Kang Chang Shou Co., Ltd. (hereinafter referred to as Party A) Legal representative: CHEN Jiping Contact information: [*] Transferee: Ankang Huazhuo Health Management Co., Ltd. (hereinafter referred to as Party B) Legal representative: ZHANG Yuankai Contact information: [*] Whereas Party A lawfully owns 49% equity in Shaanxi Pharmaceutical Sun |
|
| May 14, 2021 |
Exhibit 10.6 THIS STOCK PURCHASE AGREEMENT (THIS "AGREEMENT") RELATES TO AN OFFER AND SALE OF SECURITIES IN AN OFFSHORE TRANSACTION TO PERSONS WHO ARE NOT U.S. PERSONS (AS DEFINED HEREIN) PURSUANT TO REGULATION S (AS DEFINED HEREIN) UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT"). ?????????????????????????????????????????????1933??????????????????S??????????? NONE |
|
| May 14, 2021 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-37776 SHINECO, INC. (E |
|
| May 14, 2021 |
Exhibit 10.4 Loan Extension Agreement Contract No.: 61010220210000109 Dear customer: in order to protect your rights and interests, before you sign this contract, please carefully read all terms of this contract (especially those in bold font), and pay attention to your rights and obligations under this contract. Please consult the lending bank if you have any question on this contract. To consult |
|
| May 14, 2021 |
Exhibit 10.2 Equity Transfer Agreement Transferor: An Kang Chang Shou Co., Ltd. (hereinafter referred to as Party A) Legal representative: CHEN Jiping Contact information: [*] Transferee: Ankang Huazhuo Health Management Co., Ltd. (hereinafter referred to as Party B) Legal representative: ZHANG Yuankai Contact information: [*] Whereas Party A lawfully owns 49% equity in Shaanxi Pharmaceutical Hold |
